Additionally, although CSF3 has been applied as a supportive therapy to prevent or treat chemotherapy-associated neutropenia in cancer patients, emerging investigations have drawn attention to the tumor-promoting effects of CSF3 on myeloid cells34,35. The gene discussed is CSF3; the disease is Decreased total neutrophil count.